http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150013657-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 |
| filingDate | 2013-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150013657-A |
| titleOfInvention | Methods for the treatment of overactive bladder |
| abstract | Disclosed herein is a method of treating an overactive bladder in a patient, comprising: identifying a patient in need of treatment of an overactive bladder; And administering to said patient a composition comprising tolterodine or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable salt thereof, wherein after administration, the C max for tolterodine is 1.0 to 8.0 ng / ml. |
| priorityDate | 2012-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.